Restoring the gut ecology
behind metabolic health.
Amara develops standardized ecological therapeutics from precision-fermented plant matrices — beginning with physician-supervised support for GLP-1 tolerability, gut-metabolic resilience, and long-term metabolic health.
The GLP-1 era revealed a gut-restoration gap.
These synthetic GLP-1 drugs have transformed metabolic medicine. But many patients still struggle with GI side effects, discontinuation, weight regain after stopping, and the broader metabolic dysfunction that extends beyond any single receptor pathway.
Amara is building ecological therapeutics designed to support the upstream gut ecosystem involved in metabolic health.
Amara
Restore.
A precision multi-kingdom fermentation plant matrix designed for metabolic care.
- A probiotic.
- Kombucha.
- A meal replacement.
- A single-ingredient supplement.
A standardized ecological matrix created from selected plant substrates and controlled bacterial guilds, yeast guilds, and fungi — designed to generate gut-relevant metabolites, support microbial cross-feeding, and improve metabolic resilience.
A three-stage protocol — from structured plant substrates to standardized productization.
Structured plant substrates.
Plant and grain matrices selected for fiber architecture, resistant starch, polyphenols, and fermentable carbohydrates. First program: banana, millet, sorghum.
Precision ecological fermentation.
Bacteria, yeasts, and fungi are guided through controlled fermentation to transform the substrate into a more biologically active ecological matrix.
Standardized clinical productization.
Each product is being developed for reproducibility, batch characterization, safety, and use in real-world metabolic care.
A three-stage protocol —
from structured plant substrates
to standardized productization.
Structured plant substrates.
Plant and grain matrices selected for fiber architecture, resistant starch, polyphenols, and fermentable carbohydrates. First program: banana, millet, sorghum.
Precision ecological fermentation.
Bacteria, yeasts, and fungi are guided through controlled fermentation to transform the substrate into a more biologically active ecological matrix.
Standardized clinical productization.
Each product is being developed for reproducibility, batch characterization, safety, and use in real-world metabolic care.
Most metabolic drugs activate a single receptor.
We design matrices that may support
multiple upstream systems at once.
-
01Gut hormone tone.Supporting endogenous incretin and satiety-related signaling.
-
02Microbial metabolites.Supporting short-chain fatty acid ecology and gut microbial function.
-
03Gut barrier integrity.Supporting the intestinal barrier involved in inflammation and metabolic health.
-
04Bile-acid signaling.Engaging gut-liver pathways linked to glucose, lipids, and incretin biology.
-
05Metabolic resilience.Supporting healthier responses to meals, glucose dynamics, and long-term maintenance.
Built alongside the people delivering metabolic care.
Practices delivering supervised metabolic care.
Obesity medicine, metabolic health, endocrinology, gastroenterology, and functional medicine practices interested in supervised metabolic protocols.
Organizations building differentiated metabolic-health programs.
Clinics, telehealth platforms, food-as-medicine programs, payers, and care organizations.
People in active metabolic care.
People working on weight, blood sugar, GLP-1 therapy, gut health, or long-term metabolic maintenance.